Formycon AG is a startup based in Germany, 1 tracked investor.
Formycon AG is a company founded in 2009 headquartered in Germany. Brouky records 1 investor associated with the company.
Formycon AG is a German biopharmaceutical company that develops high-quality biosimilar medicines. They focus on creating follow-on versions of approved biopharmaceutical drugs, primarily in ophthalmology, immunology, and other chronic diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.